NCT04088682 Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
| NCT ID | NCT04088682 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China National Center for Cardiovascular Diseases |
| Condition | ST Elevation Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 200,000 participants |
| Start Date | 2018-07-15 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200,000 participants in total. It began in 2018-07-15 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction (STEMI) in China. Further more, the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI. This is a annually survey , through consecutively recruiting all eligible inpatients and collecting relevant medical information, the performance of all participating hospitals. Further, quality improvement strategies including summary of clinical performance and quality measures, clinical pathways and team building will be organized for the purpose of quality improvement. All hospitals will consecutively recruit qualified patients in the same method adopted in baseline period. Then the reperfusion rates and other performance measures will be compared annually.
Eligibility Criteria
Inclusion Criteria: * Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset. Exclusion Criteria: * None
Contact & Investigator
Zhe Zheng
PRINCIPAL INVESTIGATOR
Chinese Academy of Medical Sciences, Fuwai Hospital
Frequently Asked Questions
Who can join the NCT04088682 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ST Elevation Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04088682 currently recruiting?
Yes, NCT04088682 is actively recruiting participants. Contact the research team at wanghongjianfw@hotmail.com for enrollment information.
Where is the NCT04088682 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT04088682 clinical trial?
NCT04088682 is sponsored by China National Center for Cardiovascular Diseases. The principal investigator is Zhe Zheng at Chinese Academy of Medical Sciences, Fuwai Hospital. The trial plans to enroll 200,000 participants.